MCRB

$1.96+7.10%visit website

Seres Therapeutics, Inc.

Market Cap

$19M

Live price × SEC shares (Aug 3, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.43

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

10.3

TTM to Jun 2026 · revenue

P/B

0.6

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	351	438	358	736	1,883
Research & development	12,616	11,684	13,195	9,141	46,636
Total operating expenses	22,828	19,815	21,265	22,009	85,917
Operating income	(22,477)	(19,377)	(20,907)	(21,273)	(84,034)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	8,204	(15,335)	(19,913)	4,581	(22,463)
EPS (basic) ($)	0.94		(2.08)	0.47	(2.42)
EPS (diluted) ($)	0.94		(2.08)	0.47	(2.42)
Weighted avg. shares (basic)	8,759		9,583	9,706
Weighted avg. shares (diluted)	8,772		9,583	9,747

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 5, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 46 more quarters, back to Mar 2014, with Tormere Pro.

Corporate Events (8-K)

2 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 4, 2026 accepted 7:05 AM ET	2.02Earnings release7.01Reg FD disclosure	SEC ↗
Oct 26, 2026 accepted 4:30 PM ET	5.02Officer / director change	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

51%

W/W +20.7pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

3.61x

Avg Daily Selling (90d)

5.4 sh/day

Baseline Daily Selling

4.0 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-17	2026-08-18	Shaff Eric D.	Director	Sale	263	$4.55	$1K	12.5K	View
2026-08-17	2026-08-18	Henn Matthew R	See Remarks	Sale	81	$4.55	$368.55	7,995	View
2026-08-17	2026-08-18	Brady Kelly	See Remarks	Sale	64	$4.55	$291.20	8,679	View
2026-08-17	2026-08-18	DesRosier Thomas	See Remarks	Sale	82	$4.55	$373.10	8,117	View
2026-05-18	2026-05-19	Brady Kelly	See Remarks	Sale	59	$7.53	$444.27	8,562	View

1–5 of 12

1 / 3

MCRB

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Seres Therapeutics, Inc. (MCRB)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-08-17	Shaff Eric D.	S	263	$1,196.65
2026-08-17	Henn Matthew R	S	81	$368.55
2026-08-17	Brady Kelly	S	64	$291.2
2026-08-17	DesRosier Thomas	S	82	$373.1
2026-05-18	Brady Kelly	S	59	$444.27